Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001765581-23-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-05 | JAZZ | Iannone Robert | EVP, Gbl Head of Research a | F - Tax | $142.78 | -2,274 | 46.5K | -5% | -$324.7K | |
| 2023-03-07 | 2023-03-03 | JAZZ | Iannone Robert | EVP, Gbl Head of Research a | A - Grant | $0.00 | +12.4K | 48.8K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-05 | F | D | 2,274 | $142.78 | 46,489 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-03-03 | A | A | 12,447 | $0.00 | 48,763 | D | — | — |